This inventor holds 1 USPTO granted patent. Top assignee: Academia Sinica. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Meng-Jhe Chung: Innovator in Tumor Treatment
Introduction
Meng-Jhe Chung is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical research, particularly in the area of cancer treatment. His innovative work focuses on developing targeted therapies that can improve patient outcomes.
Latest Patents
Meng-Jhe Chung holds a patent titled "Ligands Targeted to Epidermal Growth Factor Receptors and Compositions for Use in Treating Tumors." This patent represents a crucial advancement in the development of therapies aimed at combating tumors by targeting specific receptors involved in cancer progression. He has 1 patent to his name, showcasing his commitment to innovation in the medical field.
Career Highlights
Chung is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to collaborate with leading scientists and contribute to groundbreaking research in cancer treatment. His dedication to advancing medical science is evident in his research and patent contributions.
Collaborations
One of his notable collaborators is Yi-Ping Wang. Together, they have worked on various projects aimed at enhancing the understanding and treatment of tumors. Their partnership exemplifies the collaborative spirit of scientific research.
Conclusion
Meng-Jhe Chung is a key figure in the field of cancer research, with a focus on targeted therapies. His innovative patent and work at Academia Sinica highlight his contributions to improving treatment options for patients. His ongoing research promises to further advance the field of oncology.